Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Interpace Diag Group (IDXG)

Interpace Diag Group (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,895
  • Shares Outstanding, K 4,370
  • Annual Sales, $ 40,210 K
  • Annual Income, $ 800 K
  • 60-Month Beta 0.67
  • Price/Sales 0.13
  • Price/Cash Flow 1.83
  • Price/Book N/A
Trade IDXG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.10
  • Most Recent Earnings $0.13 on 05/09/24
  • Next Earnings Date 08/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0100 +13.86%
on 07/26/24
1.2600 -8.73%
on 07/17/24
+0.0500 (+4.55%)
since 06/26/24
3-Month
1.0100 +13.86%
on 07/26/24
1.6000 -28.13%
on 06/04/24
-0.3500 (-23.33%)
since 04/26/24
52-Week
0.7650 +50.33%
on 08/24/23
2.6000 -55.77%
on 04/05/24
-0.8000 (-41.03%)
since 07/26/23

Most Recent Stories

More News
Interpace Biosciences Announces First Quarter 2022 Financial and Business Results

 ●Q1 Revenue of $10.4 million up 6% versus Prior Year ●Q1 Net Loss improved $2 million versus Prior Year ●Days Sales Outstanding (DSO) decreased by 27% ...

IDXG : 1.1500 (+2.68%)
Interpace Biosciences Announces Full Year and Fourth Quarter 2021 Financial and Business Results

 ●2021 Full Year Net Revenue of $41.3 Million up 28% vs Prior Year; Fourth Quarter Net Revenue of $10.9 Million up 13% vs Prior Year  ●2021 Full Year Net...

IDXG : 1.1500 (+2.68%)
Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of its Thyroid Tests

PARSIPPANY, NJ, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling...

IDXG : 1.1500 (+2.68%)
Interpace Biosciences Announces Appointment of Vijay Aggarwal, Ph.D. as New Director

PARSIPPANY, NJ, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences , Inc. (OTCQX: IDXG) (“Interpace”) a leader in enabling personalized medicine, is...

IDXG : 1.1500 (+2.68%)
Interpace Biosciences Announces Commencement of Fully Back-Stopped $30 Million Rights Offering

PARSIPPANY, NJ, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it...

IDXG : 1.1500 (+2.68%)
Interpace Biosciences Announces Record Date for Proposed Fully Back-Stopped $30 Million Rights Offering

Proceeds to be used to fund the organic growth and prospective product line acquisitions PARSIPPANY, NJ, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Interpace...

IDXG : 1.1500 (+2.68%)
Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity Loans

PARSIPPANY, NJ, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it, along...

IDXG : 1.1500 (+2.68%)
Interpace Biosciences Announces U.S. PTO Issuance of Patent No. 11,143,657 Titled: Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related Conditions

PARSIPPANY, NJ, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial...

IDXG : 1.1500 (+2.68%)
Interpace Diagnostics Announces US Patent Approval for Patent Application No. 11,118, 231 B2 Titled: microRNAs as Biomarkers for Distinguishing Benign from Malignant Thyroid Neoplasms

PARSIPPANY, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial...

OTC.VN : 0.310 (+6.90%)
IDXG : 1.1500 (+2.68%)
Interpace Biosciences Announces Second Quarter 2021 Financial and Business Results

PARSIPPANY, NJ, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fiscal quarter ended June...

IDXG : 1.1500 (+2.68%)

Business Summary

Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services....

See More

Key Turning Points

3rd Resistance Point 1.3533
2nd Resistance Point 1.2567
1st Resistance Point 1.2033
Last Price 1.1500
1st Support Level 1.0533
2nd Support Level 0.9567
3rd Support Level 0.9033

See More

52-Week High 2.6000
Fibonacci 61.8% 1.8990
Fibonacci 50% 1.6825
Fibonacci 38.2% 1.4660
Last Price 1.1500
52-Week Low 0.7650

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar